StrategIQ Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$363K Buy
770
+227
+42% +$105K 0.04% 244
2023
Q3
$236K Buy
543
+11
+2% +$4.99K 0.03% 276
2023
Q2
$236K Hold
532
0.03% 280
2023
Q1
$245K Hold
532
0.03% 260
2022
Q4
$273K Buy
+532
New +$270K 0.03% 242
2022
Q3
Sell
-417
Closed -$201K 277
2022
Q2
$201K Hold
417
0.02% 273
2022
Q1
$205K Buy
+417
New +$191K 0.02% 287

Other funds holding ELV

StrategIQ Financial Group's ELV Position: Q4 2023 in Review

StrategIQ Financial Group increased its Elevance Health (ELV) stake by 42% in Q4 2023, buying an estimated $105K and bringing the position to 770 shares worth $363K. The position accounts for 0.04% of the portfolio, ranked #244.

StrategIQ Financial Group first reported a position in ELV in Q1 2022 and has held it in 7 quarters since. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • StrategIQ Financial Group held 770 shares of Elevance Health worth $363K as of Q4 2023.
  • StrategIQ Financial Group bought 227 Elevance Health shares in Q4 2023, an estimated $105K.
  • Elevance Health made up 0.04% of StrategIQ Financial Group's portfolio in Q4 2023, its #244 holding.
  • StrategIQ Financial Group first reported a position in Elevance Health in Q1 2022 and has held it in 7 quarters since.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on StrategIQ Financial Group's 13F filing for Q4 2023, filed 23 Jan 2024.